Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program Agenus Inc. (“Agenus” or the ...

Brazil's Lula won't attend EU-Mercosur deal signing: presidency source Agenus Inc. ( Nasdaq: AGEN ), a leader in immuno-oncology innovation, today announced the closing of its previously disclosed ...

The program debuts with two certification tracks available through the Kiteworks Partner Portal. The training modules leverage AI video technology and range from two to 10 minutes. They feature Sophia ...

Bot Auto will begin driver-out commercial freight operations in 2025 with a pilot program between Houston and San Antonio. The pilot aims to evaluate actual usage and profitability of autonomous ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus” or the “Company”) (Nasdaq: AGEN), an immuno-oncology company advancing innovative cancer therapies, today reported financial and operational ...